Company profile
Action Pharma company profile
Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modified ÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid..... For more information, log in to dureach.com to view the full company profile.
Business identity
- Website
- http://www.actionpharma.com
- Contact email
- [email protected]
- Phone number
- +(45) 2020 3687
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Founded
- 2000-01-01
Headquarters
- Headquarters
- Århus, Central Jutland, Denmark
- Postal code
- 8200
- Country code
- DK
- Continent
- Europe